🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Classic Hodgkin Lymphoma

Comparison of AVD + Low-Dose Nivolumab vs. PET-Adapted BEACOPP-like in Advanced cHL NCT07234487Phase 23 sites📍 Moscow📍 Moscow📍 Saint Petersburg St. Petersburg State Pavlov Medical University · Tests: Nivo-AVD, BEACOPP-like MT2022-60: Ph 2 Study of Pembro+ BEAM With ASCT for Relapsed Hodgkin Lymphoma NCT06377540Phase 21 site📍 Minneapolis Masonic Cancer Center, University of Minnesota · Tests: Pembrolizumab, Autologous stem cell transplant, Carmustine, Etoposide, Cytarabine Pembrolizumab and Brentuximab Vedotin vs GDP and Stem Cell Transplant for Relapsed/Refractory Hodgkin Lymphoma NCT05180097Phase 218 sites📍 Concord📍 Nowra📍 Wollongong Canadian Cancer Trials Group · Tests: Gemcitabine, Dexamethasone, Cisplatin, Brentuximab vedotin, Pembrolizumab Nivo40-AVD for Advanced Classic Hodgkin Lymphoma NCT06984146Phase 21 site📍 Moscow National Medical Research Radiological Centre of the Minist… · Tests: Nivolumab, Doxorubicin, Vinblastine, Dacarbazine Brentuximab Vedotin and Nivolumab for the Treatment of Patients With Relapsed/Refractory Classical Hodgkin Lymphoma NCT04561206Phase 25 sites📍 Duarte📍 Chicago📍 Boston City of Hope Medical Center · Tests: Brentuximab Vedotin, Nivolumab Pianzumab Combined With AVD Regimen in the Treatment of Newly-diagnosed Advanced Classic Hodgkin Lymphoma NCT05949931Phase 21 site📍 Guangzhou Sun Yat-sen University · Tests: Concurrent penpulimab and AVD, Sequential penpulimab and AVD Azacitidine Plus PD-1 Therapy for R/R Hodgkin Lymphoma NCT06190067Phase 21 site📍 Beijing Navy General Hospital, Beijing · Tests: Azacitidine Plus PD-1 therapy Changing Paragidms In The Prognostic Assessment Of Hodgkin Lymphoma NCT06822855n/a12 sites📍 Milan📍 Reggio Emilia📍 Avellino Azienda USL Reggio Emilia - IRCCS Study of Pembrolizumab With Bendamustine in Hodgkin Lymphoma NCT04510636Phase 21 site📍 Toronto University Health Network, Toronto · Tests: Pembrolizumab, Bendamustine Hydrochloride Chidamide Decitabine Plus Anti-PD-1 Antibody for Patients With R/R cHL Who Are Transplant-ineligible or Refused Transplant. NCT06393361Phase 21 site📍 Beijing Chinese PLA General Hospital · Tests: Chidamide; Decitabine; Anti-PD-1 Antibody, Brentuximab Vedotin, anti-PD-1 antibody. PD-1 Inhibitors Maintenance for cHL Post-autoHCT NCT06812858Phase 24 sites📍 Astana📍 Moscow📍 Moscow St. Petersburg State Pavlov Medical University · Tests: Nivolumab, Pembrolizumab PET-Adapted First-Line Therapy With Nivolumab for Advanced Hodgkin Lymphoma NCT07209059Phase 21 site📍 Moscow National Research Center for Hematology, Russia · Tests: Nivolumab, N-EACOPD-14, N-AVD Lifestyles Implemented-Survivorship Care Plan In Lymphoma Survivors NCT05934084NA40 sites📍 Ancona📍 Aviano📍 Bari Fondazione Italiana Linfomi - ETS · Tests: Lifestyles Implemented-Survivorship Care Plan (LS-SCP) Brentuximab Vedotin and Nivolumab for the Treatment of Relapsed/Refractory Classic Hodgkin Lymphoma Previously Treated With Brentuximab Vedotin or Checkpoint Inhibitors NCT05039073Phase 22 sites📍 Atlanta📍 Atlanta Emory University · Tests: Brentuximab Vedotin, Hematopoietic Cell Transplantation, Nivolumab, Quality-of-Life Assessment, Questionnaire Administr… Immunotherapy in Lymphoma NCT06796517n/a2 sites📍 Seoul📍 Seoul Sung-Soo Park · Tests: CAR-T Therapy, Bispecific antibody, Antibody-Drug Conjugate, Monoclonal antibody, Proteasome Inhibitor Brentuximab Vedotin for Newly Diagnosed cHL in Chinese CAYA Based on PET/CT Assessment NCT06563245Phase 2, Phase 31 site📍 Shanghai Children's Cancer Group, China · Tests: Brentuximab Vedotin for Injection, response-adapted radiation, Doxorubicin, Etoposide, Prednisone Personalized Reduction of Chemotherapy Intensity Through ctDNA Evaluation for the Treatment of Patients With Advanced Hodgkin Lymphoma NCT06745076Phase 26 sites📍 Irvine📍 Palo Alto📍 Boston University of Washington · Tests: Biospecimen Collection, Computed Tomography, Dacarbazine, Doxorubicin, Echocardiography Test A Study of Brentuximab Vedotin With Doxorubicin, Vinblastine and Dacarbazine in Adults With Hodgkin Lymphoma in India NCT06831370Phase 411 sites📍 Vijayawada📍 Guwahati📍 Surat Takeda · Tests: Brentuximab Vedotin, Doxorubicin, Vinblastine, Dacarbazine A Study of AK129 With or Without AK117 in PD(L)1-refractory Classic Hodgkin Lymphoma NCT06642792Phase 1, Phase 21 site📍 Beijing Akeso · Tests: AK129, AK117 Phase II Study Of Nivolumab Plus AVD In Pediatric, Adolescent, And Young Adult Patients With CHL NCT07551583Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Nivolumab, Doxorubicin Hydrochloride, Vinblastine, Dacarbazine Pembrolizumab in Combination With Salvage Chemotherapy for First-relapsed or Refractory Classical Hodgkin Lymphoma NCT04838652Phase 21 site📍 Cologne University of Cologne · Tests: Pembrolizumab plus Chemotherapy (ICE or DHAP) Sintilimab Plus AVD in Pediatric Low/Moderate Risk Hodgkin Lymphoma: A Phase II Study NCT06848569Phase 21 site📍 Guangzhou Sun Yat-sen University · Tests: Sintilimab in combination with AVD chemotherapy Epcoritamab With Dose Adjusted Etoposide, Cyclophosphamide, Vincristine, Doxorubicin, Prednisone and Rituximab (EPOCH-R) for the Treatment of Aggressive B-Cell Non-Hodgkin Lymphoma NCT07097363Phase 21 site📍 Seattle University of Washington · Tests: Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy, Computed Tomography, Cyclophosphamide ctDNA-Guided Therapy for Relapsed/Refractory Hodgkin Lymphoma NCT07021989Phase 26 sites📍 Davis📍 Fresno📍 Irvine Michael Spinner, MD · Tests: Pembrolizumab, Non-investigational, involved site radiotherapy (ISRT), Gemcitabine, Vinorelbine, Liposomal Doxorubicin Liquid Biopsy in Mature B-cell Tumors NCT03280394n/a1 site📍 Bellinzona Oncology Institute of Southern Switzerland · Tests: Liquid Biopsy A Phase III Clinical Study Comparing JS004 Plus Toripalimab With Investigator-Selected Chemotherapy in Patients With PD-(L)1monoclonal Antibody Refractory Classic Hodgkin Lymphoma (cHL) NCT06170489Phase 31 site📍 Beijing Shanghai Junshi Bioscience Co., Ltd. · Tests: JS004 in combination with Toripalimab, Bendamustine or gemcitabine Pembrolizumab in Combination With Chemotherapy for the Treatment of Frail Hodgkin Lymphoma Patients Ineligible for Standard Treatment NCT07275216Phase 21 site📍 Duarte City of Hope Medical Center · Tests: Biospecimen Collection, Brentuximab Vedotin, Computed Tomography, Dacarbazine, Echocardiography Test A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma NCT05705531n/a36 sites📍 Mobile📍 Phoenix📍 Duarte Children's Oncology Group · Tests: Archive Sample Retrieval, Biospecimen Collection, Electronic Health Record Review, Magnetic Resonance Imaging, Survey A… A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051) NCT02332668Phase 1, Phase 216 sites📍 Aurora📍 Chicago📍 Boston Merck Sharp & Dohme LLC · Tests: Pembrolizumab Treatment for Classical Hodgkin Lymphoma in Children and Adolescents NCT02797717NA1 site📍 Petah Tikva GALIA AVRAHAMI · Tests: Radiotherapy:, Vincristine, Etoposide, Prednisone, Doxorubicin
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy